Ironwood Pharmaceuticals Initiates Phase IIa Clinical Study of IW-9179 in Diabetic Gastroparesis
https://investor.ironwoodpharma.com/press-releases/press-release-details/2014/Ironwood-Pharmaceuticals-Initiates-Phase-IIa-Clinical-Study-of-IW-9179-in-Diabetic-Gastroparesis/default.aspx
Ironwood Pharmaceuticals Initiates Phase IIa Clinical Study of IW-9179 in Diabetic Gastroparesis
https://investor.ironwoodpharma.com/press-releases/press-release-details/2014/Ironwood-Pharmaceuticals-Initiates-Phase-IIa-Clinical-Study-of-IW-9179-in-Diabetic-Gastroparesis/default.aspx
Ironwood Earns $15 Million Milestone from Astellas upon Initiation of Enrollment in Linaclotide Phase III IBS-C Clinical Trial in Japan
https://investor.ironwoodpharma.com/press-releases/press-release-details/2014/Ironwood-Earns-15-Million-Milestone-from-Astellas-upon-Initiation-of-Enrollment-in-Linaclotide-Phase-III-IBS-C-Clinical-Trial-in-Japan/default.aspx
Ironwood Earns $15 Million Milestone from Astellas upon Initiation of Enrollment in Linaclotide Phase III IBS-C Clinical Trial in Japan
https://investor.ironwoodpharma.com/press-releases/press-release-details/2014/Ironwood-Earns-15-Million-Milestone-from-Astellas-upon-Initiation-of-Enrollment-in-Linaclotide-Phase-III-IBS-C-Clinical-Trial-in-Japan/default.aspx
Ironwood Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference
https://investor.ironwoodpharma.com/press-releases/press-release-details/2014/Ironwood-Pharmaceuticals-to-Present-at-Credit-Suisse-2014-Healthcare-Conference/default.aspx
Ironwood Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference
https://investor.ironwoodpharma.com/press-releases/press-release-details/2014/Ironwood-Pharmaceuticals-to-Present-at-Credit-Suisse-2014-Healthcare-Conference/default.aspx
Ironwood Pharmaceuticals Provides Third Quarter 2014 Investor Update
https://investor.ironwoodpharma.com/press-releases/press-release-details/2014/Ironwood-Pharmaceuticals-Provides-Third-Quarter-2014-Investor-Update/default.aspx
Ironwood Pharmaceuticals Initiates Phase III Trial of 72 mcg Linaclotide in Adult Patients with Chronic Idiopathic Constipation
https://investor.ironwoodpharma.com/press-releases/press-release-details/2014/Ironwood-Pharmaceuticals-Initiates-Phase-III-Trial-of-72-mcg-Linaclotide-in-Adult-Patients-with-Chronic-Idiopathic-Constipation/default.aspx
Ironwood Pharmaceuticals Provides Third Quarter 2014 Investor Update
https://investor.ironwoodpharma.com/press-releases/press-release-details/2014/Ironwood-Pharmaceuticals-Provides-Third-Quarter-2014-Investor-Update/default.aspx
Ironwood Pharmaceuticals Initiates Phase III Trial of 72 mcg Linaclotide in Adult Patients with Chronic Idiopathic Constipation
https://investor.ironwoodpharma.com/press-releases/press-release-details/2014/Ironwood-Pharmaceuticals-Initiates-Phase-III-Trial-of-72-mcg-Linaclotide-in-Adult-Patients-with-Chronic-Idiopathic-Constipation/default.aspx